Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:55 AM
Ignite Modification Date:
2025-12-25 @ 3:55 AM
NCT ID:
NCT05621902
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytology proven non-small cell lung cancer (NSCLC)
* NSCLC stage III or IV
* ≥ 18 years
* ECOG performance status 0- 2
* Eligible patients should have initiated first-line treatment for advanced or metastatic disease with chemotherapy and/or immunotherapy, radiochemotherapy or targeted treatment
* Patients are eligible for inclusion if they have responded to first-line treatment with stable disease, or better, at the first radiological evaluation performed up to six months after start of treatment
* Stable disease, or better, on radiological assessment within 28 days of enrolment (CT scan or FDG-PET/CT. Cerebral MRI if known brain metastasis)
* Initial web-based application score of ≤ 6
* Basic computer literacy
* Bank-ID (electronic identification system) and access to "1177 Vårdguiden"
* The subject has given written consent to participate in the study
Exclusion Criteria:
* Symptomatic brain metastases
* Pregnancy, breastfeeding, or planned pregnancy
* Persons under guardianship or deprived of liberty
* Mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of study participation
* Treatment or disease which, according to the investigator, can affect treatment or study results
* Ongoing participation in another interventional clinical study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05621902
Study Brief:
Protocol Section:
NCT05621902